跳至主要内容
临床试验/IRCT2012092910933N1
IRCT2012092910933N1已完成3 期

Evaluating the effect of low dose vs moderate dose clofibrate on decreasing serum bilirubin in healthy full term neonates

Hamadan University of Medical Sciences0 个研究点目标入组 132 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 1 year(—)
性别
All

入选标准

  • Inclusion criteria included: (a) age of 2 to 29 days; (b) full term newborn (gestational age between 38 to 40 weeks); (c) weight of 2500 to 4000 gr; having indirect hyperbilirubinemia (TSB>16 mg/dl) ; (d) absence of hemolysis, ABO or Rh incompatibility; (e) negative coomb’s test; (f) reticulocyte count less than 5%.
  • Exclusion criteria : The neonates with sign of sepsis, electrolyte impairment, any congenital anomalies or disease, seizure, formula feeding, hemolytic disease and those who need exchange transfusion were excluded from the study.

排除标准

  • 未提供

研究者

相似试验